CommentEthical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships
REFERENCES (12)
- et al.
Generating comparative evidence on new drugs and devices before approval
Lancet
(2020) - et al.
Generating comparative evidence on new drugs and devices after approval
Lancet
(2020) - et al.
Surrogate endpoints in randomised controlled trials: a reality check
Lancet
(2019) Novel neurotechnologies: intervening in the brain
The role of decision aids in depression care
JAMA Intern Med
(2015)- et al.
A web-based clinical decision tool to support treatment decision-making in psychiatry: a pilot focus group study with clinicians, patients and carers
BMC Psychiatry
(2017)
There are more references available in the full text version of this article.
Cited by (4)
Brexpiprazole versus placebo or other antidepressive agents for treating depression
2023, Cochrane Database of Systematic Reviews
© 2020 Elsevier Ltd. All rights reserved.